ACRS · Aclaris Therapeutics, Inc. · Documents
$3.96
+0.17 (+4.49%)
At close · Oct 28
Return incl. dividend (before tax)
Q1 2024 earnings call transcript
Market Cap
$557.88M
Shares
147.20M
Volume · Oct 28
2.22M
Avg daily vol (3M)
2.85M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| ARS | — | 2024-04-25 | 2023-12-31 | |
| DEFA14A | — | 2024-04-25 | — | |
| 8-K | — | 2024-03-19 | 2024-03-14 | |
| 10-K | — | 2024-02-27 | 2023-12-31 | |
| 8-K | — | 2024-02-27 | — | |
| 8-K | — | 2024-02-05 | 2024-01-31 | |
| 8-K/A | — | 2024-02-05 | 2024-01-15 | |
| 8-K | — | 2024-01-19 | 2024-01-15 | |
| 8-K | — | 2023-12-19 | — | |
| 8-K | — | 2023-11-13 | — | |
| 8-K | — | 2023-11-06 | — | |
| 10-Q | — | 2023-11-06 | 2023-09-30 | |
| 8-K | — | 2023-09-18 | — | |
| 10-Q | — | 2023-08-07 | 2023-06-30 | |
| 8-K | — | 2023-08-07 | — | |
| 8-K | — | 2023-06-12 | 2023-06-09 | |
| 8-K | — | 2023-06-02 | 2023-06-01 | |
| 8-K | — | 2023-06-01 | 2023-05-26 | |
| 8-K | — | 2023-05-08 | — | |
| 10-Q | — | 2023-05-08 | 2023-03-31 | |
| ARS | — | 2023-04-20 | 2022-12-31 | |
| DEF 14A | — | 2023-04-20 | — | |
| DEFA14A | — | 2023-04-20 | — | |
| 8-K | — | 2023-04-14 | — | |
| PRE 14A | — | 2023-04-10 | — | |
| 8-K | — | 2023-03-31 | 2023-03-30 | |
| 8-K | — | 2023-03-27 | 2023-03-23 | |
| 8-K | — | 2023-03-06 | — | |
| 8-K | — | 2023-02-23 | — | |
| 8-K | — | 2023-02-23 | — | |
| 10-K | — | 2023-02-23 | 2022-12-31 | |
| 8-K | — | 2023-01-09 | — | |
| 8-K | — | 2023-01-06 | 2022-12-31 | |
| 8-K | — | 2022-12-13 | 2022-12-09 | |
| 8-K | — | 2022-11-22 | 2022-11-18 | |
| 10-Q | — | 2022-11-08 | 2022-09-30 | |
| 8-K | — | 2022-11-08 | — | |
| 10-Q | — | 2022-08-03 | 2022-06-30 | |
| 8-K | — | 2022-08-03 | — | |
| 8-K | — | 2022-08-01 | — | |
| 8-K | — | 2022-06-03 | 2022-06-02 | |
| 10-Q | — | 2022-05-10 | 2022-03-31 | |
| 8-K | — | 2022-05-10 | — | |
| DEF 14A | — | 2022-04-21 | 2022-06-02 | |
| DEFA14A | — | 2022-04-21 | — | |
| 8-K | — | 2022-04-14 | 2022-04-13 | |
| 8-K | — | 2022-02-24 | — | |
| 10-K | — | 2022-02-24 | 2021-12-31 | |
| 8-K | — | 2022-01-14 | 2022-01-12 | |
| 8-K | — | 2021-12-07 | — |
Showing 51–100 of 143 filings
Key facts
CIK
1557746
CUSIP
00461U105
13F (30d)
26 filings
21 filers
Visit website
Investor relations